Canterbury DHB

Context

Further Reading

  1. Mastocytosis chapter in: Bentley S (2003). WHO Classification of Tumours: Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Clinical and Laboratory Haematology - CLIN LAB HAEMATOL. 25. 201-201. 10.1046/j.1365-2257.2003.00518.x.
  2. Valent P, el al. (2016). Mastocytosis 2016: Updated WHO classification and Novel Emerging Treatment Concepts.Blood 2017 129:1420-1427.
  3. Metcalfe DD (2008). Mast cells and mastocytosis. Blood 112(4): 946-56.
  4. Pardanani A (2005). Systemic mastocytosis: bone marrow pathology, classification, and current therapies. Acta Haematol 114(1): 41-51.
  5. Pardanani A, Tefferi A (2010). Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature. Curr Opin Hematol 17(2): 125-32.

About this Canterbury DHB document (540707):

Document Owner:

Andrew Butler (see Who's Who)

Issue Date:

August 2018

Next Review:

April 2021

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 540707